Want to join the conversation?
Louise Chen of Guggenheim Securities asks for an update on XIAFLEX. $ENDP said the growth profile tends to be lumpy and has some seasonal fluctuations. The company saw some slowdown in the Dupuytren's contracture market in 2Q16. Looking over the remainder of 2016, $ENDP is confident in the projected double-digit growth trajectory.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?